Breast Cancer Clinical Trial

The Active After Cancer Trial (AACT)

Summary

This study is being done to determine whether a telephone-based counseling intervention can help survivors of breast and colorectal cancer increase their weekly physical activity. Observational evidence suggests that physical activity after breast and colorectal cancer diagnosis decreases recurrence rates. Unfortunately, many people become less active during cancer therapy, and a substantial proportion never return to pre-diagnosis levels of physical activity. This study looks to see if people who have recently finished chemotherapy for breast, colon or rectal cancer can be motivated to increase their exercise by talking to an exercise specialist over the phone. The study also looks at changes in mood, fatigue, fitness, fat distribution and weight.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Histologically confirmed stage I-III breast or colorectal cancer
18 years of age or older
Completed adjuvant treatment(for current malignancy)
Completion of all adjuvant chemotherapy and radiation (with the exception of adjuvant herceptin and/or tamoxifen/aromatase inhibitor therapy for breast cancer patients) between 2 and 36 months prior to enrollment
Ability to speak and read English
Willingness to be randomized
Medical clearance from an oncologist or primary care physician stating the participant is able to participate in an unsupervised, moderate-intensity physical activity program
No major surgery within 2 months of study enrollment or planned during study period

Exclusion Criteria:

Metastatic cancer
Uncontrolled intercurrent illness including, but not limited to, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness that would limit compliance with study requirements
Plans to have hip or knee replacement within a year
Participation in more than 60 minutes a week of moderate-intensity recreational activity as assessed by the International Physical Activity Questionnaire Short Form
BMI >47

Study is for people with:

Breast Cancer

Estimated Enrollment:

120

Study ID:

NCT00548236

Recruitment Status:

Active, not recruiting

Sponsor:

Dana-Farber Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 8 Locations for this study

See Locations Near You

University of California at San Diego
La Jolla California, 92093, United States
University of California San Francisco
San Francisco California, 94143, United States
Dana-Farber Cancer Institute
Boston Massachusetts, 02115, United States
New Hampshire Oncology Hematology
Concord New Hampshire, 03106, United States
Lakes Regional Healthcare Hematology Oncology
Hooksett New Hampshire, 03106, United States
Rosewell Park Cancer Institute
Buffalo New York, 14263, United States
Hematology Oncology Associates of Central New York
East Syracuse New York, 13057, United States
Ohio State University
Columbus Ohio, 43210, United States
Vermont Cancer Center
Burlington Vermont, 05401, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

120

Study ID:

NCT00548236

Recruitment Status:

Active, not recruiting

Sponsor:


Dana-Farber Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.